Clopidogrel Treatment Before Coronary Artery Bypass Graft Surgery Increases Postoperative Morbidity and Blood Product Requirements

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 22, Issue 1, 2008, Pages 60-66

  Filsoufi, Farzan ^a   Rahmanian, Parwis B ^a   Castillo, Javier G ^a   Kahn, Ronald A ^a   Fischer, Gregory ^a   Adams, David H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

bleeding; clopidogrel; coronary artery bypass graft surgery; morbidity; mortality

Indexed keywords

AMINOCAPROIC ACID; APROTININ; CLOPIDOGREL; FENTANYL; ISOFLURANE; MIDAZOLAM;

ADULT; AGED; ARTICLE; BLEEDING; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL;

AGED; BLOOD COAGULATION TESTS; COHORT STUDIES; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TICLOPIDINE; TIME FACTORS;

EID: 39049165575     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.10.009     Document Type: Article

References (20)

1. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
2. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
3. Yende S., and Wunderink R.G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29 (2001) 2271-2275
4. Mehta R.H., Roe M.T., Mulgund J., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
5. Kapetanakis E.I., Medlam D.A., Boyce S.W., et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache?. Eur Heart J 26 (2005) 576-583
6. Ascione R., Ghosh A., Rogers C.A., et al. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution. Ann Thorac Surg 79 (2005) 1210-1216
7. Levine G.N., Berger P.B., Cohen D.J., et al. Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: A guide for pharmacists and other health care professionals. Pharmacotherapy 26 (2006) 1537-1556
8. Steinhubl S.R., Berger P.B., Mann III J.T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288 (2002) 2411-2420
9. Jauhar R., Bergman G., Savino S., et al. Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting. Am J Cardiol 84 (1999) 726-728
10. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 358 (2001) 527-533
11. Hongo R.H., Ley J., Dick S.E., et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 (2002) 231-237
12. Unsworth-White M.J., Herriot A., Valencia O., et al. Resternotomy for bleeding after cardiac operation: A marker for increased morbidity and mortality. Ann Thorac Surg 59 (1995) 664-667
13. Moulton M.J., Creswell L.L., Mackey M.E., et al. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111 (1996) 1037-1046
14. Zacharias A., and Habib R.H. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 110 (1996) 1173-1178
15. Fransen E., Maessen J., Dentener M., et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
16. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) e340-e437
17. Chen L., Bracey A.W., Radovancevic R., et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 (2004) 425-431
18. van der Linden J., Lindvall G., and Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: A double-blind, placebo-controlled, randomized clinical trial. Circulation 112 (2005) I276-I280
19. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
20. Cannon C.P., Mehta S.R., and Aranki S.F. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg 80 (2005) 768-779